Australia's Artrya falls as FY loss widens
** Shares of Artrya AYA.AX fall as much as 9.4% to A$0.29,
their lowest levels since July 29
** The medical technology co posts FY loss attributable of
A$14 mln ($9.52 mln), compared with a loss of A$11.1 mln in
previous FY
** Co posts FY revenue of A$3.7 mln, compared with A$996,000
in the year-ago period
** Artrya stock has risen 33.3% this year, as of last close
($1 = 1.4710 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on Artrya
See all newsAustralia's Artrya soars on bagging fourth US commercial customer
Brief: Artrya Reports FY Loss From Ordinary Activities After Tax Attributable A$25.2 Million
Brief: Artrya Appoints Richard Jarvis As CFO
Australia's Artrya at three-week peak on deal with US co
Brief: Artrya To Raise About A$75 Mln Via Placement At Issue Price Of A$2.05 Per Share